Glucocorticoids such as cortisol, combined with exposure-based CBT, have shown promise in reduction of fear in phobias and post-traumatic stress disorder [7] via their action on glucocorticoid receptors along the hypothalamic–pituitary–adrenal axis. The gene discussed is NR3C1; the disease is phobic disorder.